Knockdown of TRAF1 could inhibit proliferation of NSCLC cells and induce cellular apoptosis, and thus, TRAF1 was a promising diagnostic and therapeutic target for NSCLC. The gene discussed is TRAF1; the disease is non-small cell lung carcinoma.